A critical discovery in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital cancer protector protein is frequently inactivated in various forms of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research